Bram ter Harmsel

Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus

Bernhard Kleter, Leen‐Jan van Doorn, Lianne Schrauwen et al. · Journal of Clinical Microbiology · 1999 · 657 citations · Full text

Diagnostic Virology, Cancer-associated Virus, Cervical Cancer +15

Novel Short-Fragment PCR Assay for Highly Sensitive Broad-Spectrum Detection of Anogenital Human Papillomaviruses

Bernhard Kleter, Leen‐Jan van Doorn, Jan ter Schegget et al. · American Journal Of Pathology · 1998 · 513 citations · Full text

Cervical Cancer, Cancer Detection, Human Papillomavirus Vaccines +10

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Cosette M. Wheeler, S. Rachel Skinner, Maria Rowena Del Rosario‐Raymundo et al. · The Lancet Infectious Diseases · 2016 · 187 citations

Vaccination, Vaccine Safety, Vaccinology +12

2021 European guideline for the management of vulval conditions

W I van der Meijden, M. J. Boffa, Bram ter Harmsel et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 107 citations

Engineering, Gynecology, Information Sharing +20

CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies

Romy van Baars, J. van der Marel, Peter J.F. Snijders et al. · International Journal of Cancer · 2015 · 59 citations

Cervical Cancer, Cervical Health, Disease Severity +15